Novo Nordisk Plans to Cut 1,000 Jobs Amid Diabetes Price War
Novo Nordisk A/S plans to trim about 1,000 jobs, or 2 percent of the workforce at the world's biggest maker of insulin, to cut costs as it faces increasing competition and resistance to high prices for diabetes products in the U.S. Most cuts will be in research and development units and staff functions at its headquarters, as well as in the global commercial organization, the Bagsvaerd, Denmark-based company said in a statement on Thursday. The headcount reduction is part of a broader effort to pare expenses.
from Biotech News